US Patent 9914706 N-substituted pyrazolyl guanidine F
Patent 9914706 was granted and assigned to Lycera on March, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Article (+257 characters)
Article
Patent abstract
The invention provides pyrazolyl guanidine compounds that inhibit F1F0-ATPase, and methods of using pyrazolyl guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Clarke B. Taylor0
Donald J. Skalitzky0
Thomas D. Aicher0
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09914706 N-substituted pyrazolyl guanidine F US Patent 9914706 N-substituted pyrazolyl guanidine F
Infobox
Patent Number
099147060
Patent Number
99147060
Edits on 2 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
099147060
Date of Patent
March 13, 2018
0Patent Application Number
151011260
Date Filed
December 10, 2014
0Patent Primary Examiner
Edits on 19 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09914706 N-substituted pyrazolyl guanidine F
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09914706
Date of patent
March 13, 2018
Patent application number
15101126
Date Filed
December 10, 2014
Patent primary examiner
Find more entities like US Patent 9914706 N-substituted pyrazolyl guanidine F
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.